Show simple item record

dc.creatorHarth, S.C.en
dc.creatorThong, Y.H.en
dc.date.accessioned2015-05-05T18:56:36Zen
dc.date.available2015-05-05T18:56:36Zen
dc.date.created1995-08en
dc.date.issued1995-08en
dc.identifier10.1136/jme.21.4.225en
dc.identifier.bibliographicCitationJournal of Medical Ethics. 1995 Aug; 21(4): 225-228.en
dc.identifier.issn0306-6800en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Aftercare+for+Participants+in+Clinical+Research:+Ethical+considerations+in+an+Asthma+Drug+Trial&title=Journal+of+Medical+Ethics.++&volume=21&issue=4&pages=225-228&date=1995&au=Harth,+S.C.en
dc.identifier.urihttp://dx.doi.org/10.1136/jme.21.4.225en
dc.identifier.urihttp://hdl.handle.net/10822/748328en
dc.description.abstractThe issue of aftercare for participants in clinical research was explored in the context of an asthma drug trial. Although there may be financial constraints and practical difficulties with implementation, the results show that it may be feasible for clinical investigators and commercial sponsors to take on some limited responsibility for the medical care of research subjects after clinical trials. However, the ethical implications for this practice remain unclear. On the one hand, society may have a moral obligation to compensate and reward some of its members who assume the risk of research subjects for the benefit of society as a whole. On the other hand, the promise of aftercare may provide an inducement to volunteers which, under certain conditions, may be considered morally wrong and scientifically unsound.en
dc.formatArticleen
dc.languageenen
dc.sourceBRL:KIE/48120en
dc.subjectAttitudesen
dc.subjectChildrenen
dc.subjectChronically Illen
dc.subjectClinical Trialsen
dc.subjectCompensationen
dc.subjectComprehensionen
dc.subjectClinical Investigatorsen
dc.subjectClinical Researchen
dc.subjectDrug Industryen
dc.subjectDrugsen
dc.subjectEducationen
dc.subjectEvaluationen
dc.subjectEvaluation Studiesen
dc.subjectHealthen
dc.subjectHealth Educationen
dc.subjectHuman Experimentationen
dc.subjectIncentivesen
dc.subjectIndustryen
dc.subjectInvestigational Drugsen
dc.subjectInvestigatorsen
dc.subjectMinorsen
dc.subjectMoral Obligationsen
dc.subjectParentsen
dc.subjectPatient Careen
dc.subjectRandom Selectionen
dc.subjectResearchen
dc.subjectResearch Subjectsen
dc.subjectRisken
dc.subjectSurveyen
dc.subjectTherapeutic Researchen
dc.subjectVolunteersen
dc.titleAftercare for Participants in Clinical Research: Ethical Considerations in an Asthma Drug Trialen
dc.provenanceDigital citation created by the National Reference Center for Bioethics Literature at Georgetown University for the BIOETHICSLINE database, part of the Kennedy Institute of Ethics' Bioethics Information Retrieval Project funded by the United States National Library of Medicine.en
dc.provenanceDigital citation migrated from OpenText LiveLink Discovery Server database named NBIO hosted by the Bioethics Research Library to the DSpace collection BioethicsLine hosted by Georgetown University.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885